承認/再開発医薬品ライブラリー

There are five libraries in this category: Approved Drug Library, Clinical Compound Library, Drug Repurposing Library, FDA-Approved Drug Library, and Preclinical Compound Library. The purpose of such screening collections is to enable rapid testing of compounds with demonstrated safety profiles in new indications, such as neglected or rare diseases, where there is less commercial motivation for expensive research and development.

カタログ番号	製品名
L4200	FDA-Approved Drug Library	A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);	1729 compounds
L3410	Preclinical Compound Library	A unique collection of 709 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);	709 compounds
L3400	Clinical Compound Library	A unique collection of 3480 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);	3480 compounds
L1000	Approved Drug Library	A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS);	2863 compounds
L1010	FDA-Approved & Pharmacopeia Drug Library	3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);	3158 compounds
L9200	Drug Repurposing Compound Library	A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);	4630 compounds

FDA-Approved Drug Library

L4200 compounds - 1729

Preclinical Compound Library

L3410 compounds - 709

Clinical Compound Library

L3400 compounds - 3480

Approved Drug Library

L1000 compounds - 2863

FDA-Approved & Pharmacopeia Drug Library

L1010 compounds - 3158

Drug Repurposing Compound Library

L9200 compounds - 4630

本ウェブサイトに掲載されている製品は全て研究用試薬です。研究目的以外の用途にはご使用できません。

承認/再開発 医薬品ライブラリー

承認/再開発医薬品ライブラリー